Insider · CIK 0001590232

Chione Ltd

Reports to the SEC for 2 companies · 6015 LARNACA, G4

sec.gov

Transactions

Companies

Filings

CIK

0001590232

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-26	ACRVAcrivon Therapeutics, Inc.S Sale	10% Owner	SSale	−16 sh	$12.93	−$206.88	3,848,632
2023-06-15	ACRVAcrivon Therapeutics, Inc.S Sale	10% Owner	SSale	−2,056 sh	$12.14	−$25K	3,848,648
2023-06-14	ACRVAcrivon Therapeutics, Inc.S Sale	10% Owner	SSale	−893 sh	$12.13	−$10.8K	3,850,704
2023-06-13	ACRVAcrivon Therapeutics, Inc.S Sale	10% Owner	SSale	−3,000 sh	$12.30	−$36.9K	3,851,597
2023-06-12	ACRVAcrivon Therapeutics, Inc.S Sale	10% Owner	SSale	−2,000 sh	$12.34	−$24.7K	3,854,597
2022-11-17	ACRVAcrivon Therapeutics, Inc.C Conversion	10% Owner	CConversion	+10.7K sh	—	—	3,856,597
2022-11-17	ACRVAcrivon Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+400K sh	$12.50	+$5M	3,856,597
2022-11-17	ACRVAcrivon Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.45M sh	—	—	3,856,597
2022-11-17	ACRVAcrivon Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−26.3K sh	—	—	0
2022-11-17	ACRVAcrivon Therapeutics, Inc. · Series A-1 Preferred StockC Conversion	10% Owner	CConversion	−8.5M sh	—	—	0
2019-02-28	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−150K sh	$4.14	−$619K	6,000,000
2019-02-27	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−558K sh	$4.51	−$2.52M	6,149,624
2019-02-26	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−123K sh	$5.00	−$617K	6,707,867
2019-02-25	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−800K sh	$4.99	−$3.99M	6,831,267
2018-09-06	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−4,800 sh	$20.52	−$98.5K	7,631,267
2018-09-05	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−160K sh	$21.06	−$3.37M	7,636,067
2018-09-04	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−40K sh	$20.60	−$824K	7,796,067
2018-08-31	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−11.5K sh	$21.05	−$241K	7,836,067
2018-08-30	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−200K sh	$21.00	−$4.2M	7,847,535
2018-08-29	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−200K sh	$19.59	−$3.92M	8,047,535
2018-08-27	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−14K sh	$18.52	−$260K	8,247,535
2018-08-10	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−702 sh	$18.50	−$13K	8,261,561
2018-08-09	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−67.5K sh	$18.51	−$1.25M	8,262,263
2018-08-08	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−2,800 sh	$18.61	−$52.1K	8,329,737
2018-08-07	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−10.6K sh	$18.60	−$197K	8,332,537
2018-07-25	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−895 sh	$18.52	−$16.6K	8,343,139
2018-07-24	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−9,144 sh	$18.63	−$170K	8,344,034
2018-07-23	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−20K sh	$18.66	−$373K	8,353,178
2018-07-20	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−26.7K sh	$19.21	−$514K	8,373,178
2018-07-19	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−100K sh	$18.90	−$1.89M	8,399,920
2018-07-18	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−30K sh	$18.53	−$556K	8,499,920
2018-07-17	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−17.3K sh	$18.50	−$321K	8,529,920
2018-07-16	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−2,654 sh	$18.52	−$49.2K	8,547,266
2016-06-23	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−18.8K sh	$8.03	−$151K	8,549,920
2016-06-13	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−7,074 sh	$8.51	−$60.2K	8,568,744
2016-06-09	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−30K sh	$9.14	−$274K	8,575,818
2016-06-08	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−15.5K sh	$9.34	−$145K	8,605,818
2016-06-07	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−20K sh	$9.25	−$185K	8,621,359
2016-06-06	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−20K sh	$9.22	−$184K	8,641,359
2016-06-02	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−17.9K sh	$9.65	−$172K	8,661,359
2016-06-01	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−17.6K sh	$9.64	−$169K	8,679,214
2016-05-31	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−17.1K sh	$9.66	−$165K	8,696,782
2016-05-27	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−40K sh	$9.58	−$383K	8,713,878
2016-05-26	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−18.2K sh	$9.59	−$174K	8,753,878
2016-05-25	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−27.9K sh	$9.83	−$275K	8,772,060
2016-05-23	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−33.9K sh	$8.77	−$297K	8,800,000
2016-05-20	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−40K sh	$8.52	−$341K	8,833,932
2016-05-19	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−20K sh	$8.18	−$164K	8,873,932
2016-05-18	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−30K sh	$8.15	−$244K	8,893,932
2016-05-17	KPTIKaryopharm Therapeutics Inc.S Sale	10% Owner	SSale	−33.8K sh	$8.15	−$275K	8,923,932

Recent filings

Accepted (ET)
Jun 284
Chione Ltd0001213900-23-052442
SEC(opens sec.gov)
Jun 204
Chione Ltd0001213900-23-050160
SEC(opens sec.gov)
Jun 144
Chione Ltd0001213900-23-049014
SEC(opens sec.gov)
Nov 214
Chione Ltd0001213900-22-074313
SEC(opens sec.gov)
Mar 44
Chione Ltd0001213900-19-003551
SEC(opens sec.gov)
Feb 274
Chione Ltd0001213900-19-003242
SEC(opens sec.gov)
Sep 74
Smolokowski Wiaczeslaw0001213900-18-012296
SEC(opens sec.gov)
Sep 44
Chione Ltd0001213900-18-012091
SEC(opens sec.gov)
Aug 294
Smolokowski Wiaczeslaw0001213900-18-011892
SEC(opens sec.gov)

Companies

Address

SIMOU MENARDOU 8 RIA COURT 8, OFFICE 101

6015 LARNACA, G4